Delivery Order SPE2DB24D2212-SPE2DB25FHPJM
Award Date
3/31/25
Potential Completion Date
4/21/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 4,567,782,223 units of the drug NUBEQA 300 MG Tablet 120S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is a Firm Fixed Price Delivery Order for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug NUBEQA 300 MG TABLET 120S. The firm-fixed-price delivery order has a ceiling value of $7,641.98 and an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is a delivery order for the supply of 4,567,906,586 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract is a firm fixed-price arrangement with a performance period ending on May 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,283.96, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 30, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 4567881031 NUBEQA 300 MG TABLET 120S. This is a firm fixed-price delivery order contract with a completion date of May 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen is the prime contractor for this award. The company holds a significant...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NUBEQA 300 MG TABLET 120S, a specialty medication. The $9,367.94 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,641.98 and a performance period through February 3, 2025. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...